420 InvestorsThis tread is created for serious cannabis investors to share K.A.S.H. by providing ideas, diligence, links, equities, etc. with like-minded individuals.
This is a discussion topic or guest posting submitted by a Stock Gumshoe reader. The content has not been edited or reviewed by Stock Gumshoe, and any opinions expressed are those of the author alone.
Question. Does anyone know where I can find info for cannabis stock IPO’s that are coming out on the regular? I’m looking for a source that basically says something like “these are the cannabis companies who are having IPO’s this week”.
Thanks
Scott
hi hitman (Scott), January 14th I replied to your January 10, 2019 5:14 pm post, but my comment is still awaiting moderation – I think since this is a microblog started by a reader (s)he has to do the review/moderation before posting; I gave 3 free weekly cannabis enewsletters.
Trying to re-post my January 14th cannabis comment: Hi Hittman, Cannabis investing is very speculative, invest only what you can afford to lose…… I have read aprox. 15% of your total portfolio. Since April 2018 I have invested in 14 cannabis, or industry related, companies, and am now collectively up +15%, being down about 10% in December. As part of your due diligence, I suggest 3 weekly (free) enewsletters. 1. Let’s Toke Business Newsletter by Ted Ohashi. Send an email to Ted tedohashi@gmail.com and ask to be added to his newsletter and what country you are from. 2. http://www.newcannabisventures.com by… Read More »
These are mine to date, anywhere from 2 to 100 shares depending of course on the cost.
CGC, CRON, ACB, CNTTF, CWBHF, ELLXF, EMHTF, HEXO, KSHB, MMNFF, MPXEF, OGRMF, ORHOF (that’s actually origin house or CannaRoyalty), PRCNF, and TGODF. Some camfrom NIC & some from me selecting. I’m up for the most part but it doesn’t matter that much to me right now because I’m more interested in 5-10 years down the road.
Hello, hitman, I’m just getting started, only own 7 stocks. Was looking over your list, looking for validation I guess. I see you have EMHTF. I bought that because I want growers, but also because of the Pharm activity in CA. That one is my “target,” as soon as it IPO’s. They have a “venture group” now at $5 a share, but there is a $2K minimum and I can’t afford to tie up that much waiting on the FDA. What is your take on that?
I like Emerald Health mainly because of their JV with Village Farms. Emerald has a family of companies. There is also Emerald Bioscience and Emerald Pharmaceuticals which is still private. I want to get into Emerald Pharma so bad right now because like you said their shares are only $5 pre-IPO. The issue is that their minimum buy in is 5K and that is out of my range.
My comment above waiting moderation was supposed to be a reply to this one steveflick, but I did it wrong and it will come across as a new comment. Thx!
@hittman, for cannabis IPO’s, try http://www.newcannabisventures.com free weekly enewsletter by Alan Brochstein……he has Discover upcoming new listings with the curated Cannabis Stock IPOs and New Issues Tracker.
Thanks so much steveflick
@hittman, @Andrew, @sylrog, cannabis DD, please see Gumshoe article July 8, 2018, What’s “Royal Gold of Marijuana” my comment July 10, 2018 1:56 pm with 3 free weekly cannabis enewsletters.
Thank you – yes, I have used these resources. Appreciate it!
i google Yahoo marijuana IPO calendar and find IPOs: Calendar – Yahoo Finance. Just looked there are two IPOs for 2-7-19 and three IPOs on 2-8-19. They may not be pot/marijuana IPOs but you can check each one and see if it is a pot stock.
NASDQ and NYSC also IPO news
Thank you – I certainly appreciate it!
You can try https://www.crunchbase.com/
they have an IPO menu item. Also Seeking Alpha has an IPO section, and of course there is Cannabis profits daily website.
The ones I’ve seen don’t just simply lay out coming IPOs and / or any of their worth. Can you list them here again in case they are different from the ones I always look at like New Cannabis Ventures (which has very limited ipos under sedar.com) , Green Market Report, Let’s Toke by Ted Ioshi(sp)? Anything else reliable. I’m really hurting. Thx man!
Cannabis IPO’s – New Cannabis Ventures has a for pay service, I think $700 a year, that they call “420 Investor”; but I do not subscribe to that as I am a small speculative retail investor….I think that is for the larger institutional investors.
New Cannabis Ventures free weekly enewsletter at bottom has a link “Discover upcoming new listings” that leads to website https://www.newcannabisventures.com/cannabis-stock-ipos-and-new-issues/
that is updated weekly; i.e. February 1st has new IPO SLNG Slang Worldwide that IPO’d January 29th.
Hope that helps in your DD Due Diligence.
Happy Investing!
Don’t get sucked into pot ipo’ it was just another money maker angle that c.i.i along with J.b. sitting by a USA flag if you are loooking for a really solid newer stock would of rather advised you at 2.25 cent but since it is a profitable right out of the gate within the last year ipo medipharm MEDIF you might be able to grab it today with a down day I believe it was at 3.75 they are a extraction only company with huge contracts with the govt providences canopy all the way down to supreme . A definite… Read More »
Hey everyone does anyone know the 4 cannabis IPOs that Danny Brody from NIC Investors is pitching for January 31st?
Scott
Hello all. Does anyone know the 5 stocks Jimmy Mengel is talking about in his new “buyout frenzy”? It’s been a month by the way and I’m still plugging away. Have found out the hard way that NIC is set up so that the level and amount of guidance given to subscribers is based on how much you are paying them. Geez. The IPO level for example is $1900 as I’ve mentioned before but at that level you are supposed to come out the other side a millionaire. I didn’t purchase. I couldn’t even if I wanted. Hell that’s why… Read More »
Hello all. I’ve read recently about a Company called Sproutly SRUTF. For the future in beverages, they have the ONLY technology by way of Infusion Biosciences that allows them to basically make cannabis water soluble. It’s going to be very important given the fact that other beverage makers have the same problem with their ingredients separating.
41 Top Revenue Generating Cannabis Stocks Ranked as of February 15th
https://www.newcannabisventures.com/41-top-revenue-generating-cannabis-stocks-ranked-as-of-february-15th/
$EDXC > Annual Report – Endexx PK disclosure 12-31-2018 Amended
For the years ended September 30, 2018 and 2017
https://backend.otcmarkets.com/otcapi/company/financial-report/215512/content
Attorney Letter with Respect to Current Information – Attorney Letter 2018 10k and December 31, 2018 Q1
https://backend.otcmarkets.com/otcapi/company/financial-report/215598/content
No position #DYODD
Worth a little of your time to start concidering the Asian hemp market threw a full position in a company in late February that will not come up on any of your available cannabis reasorces sold off half due to a descent jump plan on adding back once the stock levels back down Company name shineco ticker TYHT Seems to be helped along by govt funding for mass raw Cbd hemp production with extremely high amounts of oil extractions company produces fabrics , medical renal products and and those funky plant extracts that Asians swear by so by far the… Read More »
What about Jimmy’s Cardiol, or Sproutly, or someone else’s suggestion of For The Earth Company?
Wow!!!!! Where has everyone gone?
Greed has turned to fear after MJ crash, lost 2/3 of profit, now LT investments.
Not sure why scrapping the bottom of any cannabis related stock would be a discussion. . Would hope most have did well or made life changing profits since 2017 keeping it pretty recent when a lot got involved . But ignoring all analysts hasn’t changed trump aside after the y charts and dilution where used when the analysts begain scratching there heads was the game changer with no more votes taking place in Canada some pretty insane theories my favorite was buy every ipo after the tilray scam , sorry if tilray scam is a topic some don’t know about… Read More »
Hey y’all does anyone know the name of the unnamed company that the guy in charge of the University of Mississippi has helping him with potential cannabis eye drops for glaucoma that he is developing?
Emerald Biosciences I believe. They are the glaucoma guys. EMBI is the symbol. Be careful, they just opened a financing round that leaves it open for them to do whatever they want whenever they want
$ACB https://twitter.com/FinFreeFlex/status/1202597139928551424?s=20 Best!
$IMLFF
News Release Issued: Jan 20, 2020 (7:30am EST)
InMed First to Advance Cannabinol (CBN) into Therapeutic Clinical Trials
VANCOUVER, Jan. 20, 2020 /CNW/ – InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (TSX:IN; OTCQX:IMLFF), a clinical stage biopharmaceutical company developing therapeutics targeting diseases with high unmet medical needs, today revealed the rare cannabinoid cannabinol (“CBN”) as the active pharmaceutical ingredient (“API”) in its two product candidates under development: INM-755 for epidermolysis bullosa (“EB”) and INM-088 for glaucoma. InMed is leading the way in the clinical development of CBN to treat human disease.
Best!
$CATB Muscular Dystrophy News have shared an article about our US$615,056 grant to
@CatabasisPharma
to study Edasalonexent, a new drug for DMD to be tested in non-ambulant boys and men.
https://musculardystrophynews.com/2020/01/17/duchenne-uk-catabasis-support-phase-2-trial-edasalonexent-dmd/
ht https://twitter.com/DuchenneUK/status/1219239283166531587?s=20 Best!
$IMLFF VANCOUVER, Jan. 16, 2020 /CNW/ – InMed Pharmaceuticals Inc. (“InMed” or “the Company”) (TSX:IN; OTCQX:IMLFF), a clinical stage biopharmaceutical company developing cannabinoid-based medications targeting diseases with high unmet medical needs, today announced that members of its senior scientific and clinical team will be attending the EB2020 World Congress, organized and funded by the Dystrophic Epidermolysis Bullosa Research Association (DEBRA), from January 19-23, 2020 in London, UK. InMed will be exhibiting preclinical data supporting the potential of its lead product candidate, INM-755, to provide symptomatic relief of EB and potentially increase skin integrity in a subset of patients. The InMed… Read More »